The main purpose of the Cancer Target Database is to classify gene responses to medications in different kinds of cancers. It includes clinical data, expert opinions, and in vitro and mouse models from RDDC. It provides thorough analysis of novel viewpoints on tumour treatment, enabling accurate medical decision-making.